| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |